Evaluating the Use of Dalbavancin for Off-Label Indications

Evaluating the Use of Dalbavancin for Off-Label Indications

(1) Background: Dalbavancin is a long-acting lipoglycopeptide antibiotic approved for skin and soft-tissue infections. Post-marketing experience suggests dalbavancin is being used for off-label indications that normally require long-term intravenous (IV) antibiotics; however, data assessing this off...

Full description

Saved in:
Bibliographic Details
Main Authors: Katherine Taylor (Author), John Williamson (Author), Vera Luther (Author), Tyler Stone (Author), James Johnson (Author), Zachary Gruss (Author), Courtney Russ-Friedman (Author), Chris Ohl (Author), James Beardsley (Author)
Format: Book
Published: MDPI AG, 2022-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items